[PDF][PDF] CpG methylation signature predicts recurrence in early-stage hepatocellular carcinoma: results from a multicenter study
J Qiu, B Peng, Y Tang, Y Qian, P Guo, M Li, J Luo… - J clin Oncol, 2017 - researchgate.net
J Qiu, B Peng, Y Tang, Y Qian, P Guo, M Li, J Luo, B Chen, H Tang, C Lu, M Cai, Z Ke, W He…
J clin Oncol, 2017•researchgate.netPurpose Early-stage hepatocellular carcinoma (E-HCC) is being diagnosed increasingly,
and in one half of diagnosed patients, recurrence will develop. Thus, it is urgent to identify
recurrence-related markers. We investigated the effectiveness of CpG methylation in
predicting recurrence for patients with E-HCCs.
and in one half of diagnosed patients, recurrence will develop. Thus, it is urgent to identify
recurrence-related markers. We investigated the effectiveness of CpG methylation in
predicting recurrence for patients with E-HCCs.
Purpose
Early-stage hepatocellular carcinoma (E-HCC) is being diagnosed increasingly, and in one half of diagnosed patients, recurrence will develop. Thus, it is urgent to identify recurrence-related markers. We investigated the effectiveness of CpG methylation in predicting recurrence for patients with E-HCCs.
researchgate.net